Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT04999241

Combined Application of EEN in the Induction of Remission in PUC

The Role of Combined Application of Exclusive Enteral Nutrition in the Induction of Remission for Children With Newly Diagnosed Moderate to Severe Ulcerative Colitis

Status
Not Yet Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Children's Hospital of Fudan University · Academic / Other
Sex
All
Age
6 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The role of exclusive enteral nutrition (EEN) in the induction of remission in pediatric patients with Crohn's disease had been well documented. But the role of EEN in children with Ulcerative Colitis (UC) was not clear. In this study, EEN will be combined with corticosteroids or infliximab in the induction of remission in pediatric UC patients with moderate to severe disease activity. The mucosal healing rate at week12 will be compared between the two groups (combine with EEN group VS non-combine group).

Detailed description

The role of exclusive enteral nutrition (EEN) in the induction of remission in pediatric patients with Crohn's disease(CD) had been well documented. Several randomized controlled trial studies found that the overall induction of remission was equipotent with EEN compared to corticosteroids for pediatric CD. However, in promoting mucosal healing and improving the nutritional status, EEN was much better than corticosteroids. But the role of EEN in children with Ulcerative Colitis (UC) was not clear. In this study, EEN will be combined with corticosteroids or infliximab in the induction of remission in pediatric UC patients with moderate to severe disease activity. The mucosal healing rate at week 12 will be compared between the two groups (combine with EEN group VS non-combine group).The sustained corticosteroid-free clinical remission rate and treatment modification rate during the first year will also be evaluated.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTexclusive enteral nutritionAdministration of a liquid formula diet with the exclusion of all other regular food for 8 weeks, then patients can administration of regular food.
COMBINATION_PRODUCTregular foodAdministration of regular food in the induction phase and the later time.

Timeline

Start date
2025-03-01
Primary completion
2026-10-01
Completion
2027-12-31
First posted
2021-08-10
Last updated
2024-07-03

Source: ClinicalTrials.gov record NCT04999241. Inclusion in this directory is not an endorsement.